This CCRU is a collaborative arrangement between Yale University, the University of Connecticut, and the Connecticut Department of Health Services. The State of Connecticut, under active cancer surveillance by the Connecticut Tumor Registry and the SEER program, is the population resource for our program. Our major theme is the improvement of screening methods for early detection of cancer through the use of epidemiological, clinical, laboratory, and behavioral sciences. This program takes advantage of the scientific strengths that already exist within the medical institutions of our State. We have also sought to involve investigators who have made major scientific contributions in related fields, but who are new to the field of cancer control research. While our principle projects focus on critical aspects of early detection, we also include studies that are designed to provide the basis for future research on techniques for control of colon cancer and a Beta-Carotene study aimed at improved management for early stage head and neck cancer patients. We continue to develop our paired community research potential with studies in Connecticut and Long Island, N.Y. Our research program has two special qualities. 1) The majority of our intervention studies are population based, facilitating generalization to other areas of the country. 2) The initial impact of improvements in early detection rates that are monitored through the cancer registries. The long-term nature of the data of the Connecticut Tumor Registry enhances the ability to detect departures from existing trend in cancer incidence and mortality. The combinations of disciplines represented in this proposal plus the unique resources available in this region provides a foundation for a exemplary cancer control research unit.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA042101-04
Application #
3093916
Study Section
(SRC)
Project Start
1989-04-01
Project End
1994-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Davies, John R; Chang, Yu-mei; Bishop, D Timothy et al. (2015) Development and validation of a melanoma risk score based on pooled data from 16 case-control studies. Cancer Epidemiol Biomarkers Prev 24:817-24
Gould Rothberg, Bonnie E; Bulloch, Kaleigh J; Fine, Judith A et al. (2014) Red meat and fruit intake is prognostic among patients with localized cutaneous melanomas more than 1mm thick. Cancer Epidemiol 38:599-607
Brenner, Bruce M; Swede, Helen; Jones, Beth A et al. (2012) Genomic instability measured by inter-(simple sequence repeat) PCR and high-resolution microsatellite instability are prognostic of colorectal carcinoma survival after surgical resection. Ann Surg Oncol 19:344-50
Soler-Vila, Hosanna; Dubrow, Robert; Franco, Vivian I et al. (2011) The prognostic role of cancer-specific beliefs among prostate cancer survivors. Cancer Causes Control 22:251-60
Chang, Yu-mei; Barrett, Jennifer H; Bishop, D Timothy et al. (2009) Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 38:814-30
Mayne, Susan T; Cartmel, Brenda; Kirsh, Victoria et al. (2009) Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx. Cancer Epidemiol Biomarkers Prev 18:3368-74
Jones, Beth A; Christensen, Alice R; Wise Sr, John P et al. (2009) Glutathione S-transferase polymorphisms and survival in African-American and white colorectal cancer patients. Cancer Epidemiol 33:249-56
Chang, Yu-mei; Newton-Bishop, Julia A; Bishop, D Timothy et al. (2009) A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer 124:420-8
Olsen, Catherine M; Zens, Michael S; Stukel, Therese A et al. (2009) Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer 124:937-44
Soler-Vilá, Hosanna; Dubrow, Robert; Franco, Vivian I et al. (2009) Cancer-specific beliefs and survival in nonmetastatic colorectal cancer patients. Cancer 115:4270-82

Showing the most recent 10 out of 81 publications